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Many inhibitor of apoptosis (IAP) family proteins inhibit apo-
ptosis. IAPs contain N-terminal baculovirus IAP repeat
domains and a C-terminal RING ubiquitin ligase domain. Dro-
sophila IAP DIAP1 is essential for the survival of many cells,
protecting them from apoptosis by inhibiting active caspases.
Apoptosis initiateswhenproteins such asReaper,Hid, andGrim
bind a surface groove inDIAP1 baculovirus IAP repeat domains
via an N-terminal IAP-binding motif. This evolutionarily
conserved interaction disrupts DIAP1-caspase interactions,
unleashing apoptosis-inducing caspase activity. A second Dro-
sophila IAP, DIAP2, also binds Rpr and Hid and inhibits apo-
ptosis in multiple contexts when overexpressed. However, due
to a lack of mutants, little is known about the normal functions
of DIAP2. We report the generation of diap2 null mutants.
These flies are viable and show no defects in developmental or
stress-induced apoptosis. Instead, DIAP2 is required for the
innate immune response to Gram-negative bacterial infection.
DIAP2 promotes cytoplasmic cleavage and nuclear transloca-
tion of the NF-B homolog Relish, and this requires the DIAP2
RINGdomain. Increasing the genetic dose of diap2 results in an
increased immune response, whereas expression of Rpr or Hid
results in down-regulation of DIAP2 protein levels. Together
these observations suggest thatDIAP2 can regulate immune sig-
naling in a dose-dependentmanner, and this can be regulated by
IBM-containing proteins. Therefore, diap2may identify a point
of convergence between apoptosis and immune signaling
pathways.
The inhibitor of apoptosis (IAP)2 family proteins contain one
or more repeats of an70-amino acid motif known as a bacu-
lovirus IAP repeat (BIR), whichmediates interactionswithmul-
tiple death activators and plays an essential role in the ability of
these proteins to inhibit cell death. IAPs also contain a C-ter-
minal RING E3 ubiquitin ligase domain that can target bound
proteins, as well as the IAP itself, for ubiquitination and in some
cases degradation (1). TheDrosophila genome encodes twoBIR
andRINGdomain-containing IAP familymembers, DIAP1 and
DIAP2, and ectopic expression of either protein inhibits apo-
ptosis (2–4). DIAP1 is required continuously in many cells to
inhibit the apical caspase Dronc and effector caspases activated
by Dronc, such as Drice (5, 6). Critical interactions between
caspases and DIAP1 are mediated by a surface groove within
each DIAP1 BIR domain and short IAP-binding motifs (IBM)
present in Dronc or Drice (7–9). Apoptosis in the fly can be
induced by expression of proteins such as Reaper, Hid, Grim,
Sickle, and Jafrac2 (the RHG proteins). Each of these proteins
contains anN-terminal IBM thatmediates competitive binding
to DIAP1 through the same BIR surface grooves that are
required for DIAP1-caspase interactions (8, 10). RHG proteins
can also promote ubiquitin-dependent degradation of DIAP1.
Both activities have the effect of liberating active caspases,
resulting in apoptosis (6). IAPs that inhibit apoptosis, as well as
inhibitory RHG counterparts, are also found inmammals (1, 3).
Several observations have suggested that DIAP2 might also
be an important apoptosis inhibitor. DIAP2 can bind Rpr and
Hid (11, 12) and the caspases Drice (4) and Strica (13). Overex-
pression of DIAP2 can also inhibit Rpr- and Hid-dependent
apoptosis, developmental apoptosis in the eye (2), as well as
apoptosis associated with decreased levels of diap1 (4). In addi-
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has been reported to result in increased susceptibility to stress-
induced apoptosis (14). RNAi of diap2 in larvae and pupae has
generated conflicting results. One group reported no effect of
heat shock-induced expression of diap2 dsRNA on develop-
mental cell death or viability (15), and second group reported
organismal lethality in response to ubiquitous diap2 dsRNA
expression (16). Finally, several RNAi-based studies in S2 cells
have also provided evidence that DIAP2 is required for the
innate immune response to Gram-negative bacteria infection
(16, 17). However, these studies came to conflicting conclu-
sions regarding the site of action for DIAP2 and involved pri-
marily use of a single long time immortalized cell line.
Activation of apoptosis and the innate immune response
both require tight control, and deregulation can lead to cancer,
neurodegenerative diseases, immunodeficiency, or chronic
inflammation (18, 19). Molecular links between apoptotic and
immune signaling pathways may exist (20–23), and DIAP2 is
an interesting candidate protein to act as a point of conver-
gence. Questions regarding the role of DIAP2 as a cell death
and/or immune regulator can best be approached through the
characterization of deletion mutant animals. In contrast with
previous work, we show here that diap2mutants are viable and
do not show increased sensitivity to a number of different cell
death stimuli. Instead, DIAP2 is required for immune defi-
ciency signaling in response to Gram-negative bacteria infec-
tion. DIAP2 promotes but is not absolutely essential for Relish
cleavage. Nonetheless, loss of DIAP2 is associated with a pro-
found defect in Relish nuclear translocation and antimicrobial
peptide (AMP) expression. Together, these results suggest that
DIAP2 regulates Relish function at several points. Interestingly,
DIAP2 levels could be dramatically reduced in cells expressing
the apoptosis inducers Rpr or Hid, suggesting an hypothesis in
which DIAP2 acts as a point of convergence between immune
and apoptotic signaling. Binding of death-inducing RHG pro-
teins may act as a safety device to prevent unwanted chronic
inflammation in the context to whichmassive cell death occurs
during development or in response to environmental stress.
Other IBM proteins may regulate DIAP2-dependent immune
responses in other contexts.
EXPERIMENTAL PROCEDURES
Fly Stocks—All transformants were generated using standard
techniques. w1118 flies were used as wild type. The P element
line used to carry out imprecise excisions in the diap2 region,
G2534, was obtained from Genexel, Korea. Excisions were car-
ried out using standard techniques. 300 independent excision
lines were characterized at the diap2 locus by genomic PCR
using the primers indicated in Fig. 1. PCR fragments amplified
from diap2 mutant genomic DNA were fully sequenced to
confirm deletion boundaries. Wild type rescue (diap2E151;
diap27.4Wt) and RINGmutant rescue (diap2E151;diap27.4C472Y)
flies were generated by introducing a 7.4-kb genomic fragment
that contains the DIAP2 open reading frame and nearby
sequences into pCaSpeR4. Transformants containing these
constructs were introduced into the diap2E151 genetic back-
ground. For the wild type 7.4-kb genomic fragment, three small
fragments (3.2, 1.2, and 3 kb) were amplified from the BAC
clone covering the DIAP2 genomic region and ligated into
pCaSpeR4withNotI, XbaI, HpaI, and XhoI, respectively. Prim-
ers 5-AAGGAAAAAAGCGGCCGCAATAACCGAATCGG-
AAAACG-3 and 5-CGCTCTAGATTGTAAGAGGGAG-3
were used to generate the 3.2-kb fragment, and primers 5-
FIGURE 1. diap2E119 and diap2E151 are diap2 null mutants. a, schematic of the diap2 locus and surrounding region. Sequences deleted in diap2E119 and
diap2E151 are indicated. diap2E119 removes 840 bp from the diap2 locus, whereas diap2E151 removes 1,460 bp. Neither deletion affects neighboring genes. The
7.4-kb genomic fragment used to rescue the diap2 mutant phenotypes is indicated. G2534 is the original P element inserted in the diap2 5-untranslated
region. Arrows indicate primer pairs used for genomic PCR. b, genomic PCR of homozygous diap2 deletionmutants using the primer pairs indicated. c, results
of RT-PCRs with primers specific for the DIAP open reading frame in different genetic backgrounds. Open reading frame sequences are expressed in wild type
(Wt) flies and in diap2E151 flies carrying diap27.4Wt or the RING-mutated rescue diap27.4C472Y construct but not in diap2E151 alone. RP49 expression is used as a
control. d,Western blot of adult flies probed with DIAP1 and DIAP2 antibodies. DIAP2, but not DIAP1, is absent in diap2E119 and diap2E151 flies.
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CGCTCTAGATAAGCAACGCTCG-3 and 5-CGCGTTAA-
CCCGACAGCCACCTGCAATC-3were used to generate the
1.2-kb fragment, and primers 5-CGCGTTAACAGGAAGTT-
AGCTAC-3 and 5-CCGCTCGAGGGGCTCGAATTTGAT-
TAGC-3 were used to generate the 3-kb fragment. For the
7.4-kb genomic fragment with the RING-mutation, changing
Cys 3 Tyr at amino acid 472, alternative primer pairs (5-
CGCTCTAGATAAGCAACGCTCG-3 and 5-CGCGTTAA-
CCCGACAGCCACCTACAATC-3) were used for the synthe-
sis of the 1.2-kb fragment. GMR-Rpr, GMR-Hid, GMR-Dronc,
GMR-Dream/Strica, GMR-DIAP2, UAS-Rpr, UAS-Hid, UAS-
P35, engrailed-Gal4, diptericin-GFP, UAS-dTak1, c564-Gal4,
hs-diap1-rnai, dreddB118, and imd1 flies have been described
previously (2, 15, 20, 21, 24–27). GMR-Drice flies, carrying
both the GMR-Drice P20 and GMR-Drice P10 subunits, were
generated by introducing Drice large (P20) or small (P10) sub-
unit coding regions into pGMR separately. Transformants car-
rying both constructs were generated by recombination. Hs-
RelishRHD flies were generated by introducing the RelishRHD
coding region into pCaSpeR-hs-act vector (15, 28). UAS-diap1-
miRNAandUAS-diap2-miRNA flieswere generated by replac-
ing 21-bp sequences within the mir-6 precursor backbone that
are loaded into the RISC complex with sequences complemen-
tary to diap1 or diap2.3
Fly Immune Challenge—AllDrosophila stocks were raised at
25 °C. One- to 3-day-old adult male flies were pricked with a
fine glass needle dipped in an overnight live culture of Enter-
obacter cloacae or Staphylococcus aureus, resuspended at 20
concentration in sterile S2 cell medium.
Irradiation-induced Stress—Forty wild type or diap2E151 3rd
instar larvae were placed in 1.5-ml tubes and X-irradiated with
2000 or 4000 rads. Subsequently, they weremoved to fresh vials
and scored for hatching efficiency. Each experiment was
repeated three times. Error bars on figures indicate the stand-
ard deviation.
Oxidative Stress—One- to 3-day-old adult males were put in
vials (20 flies to a vial, total five vials), with eight filter paper
disks soakedwith 500l of 5% sucrose and 20mMmethyl violo-
gen (paraquat). Each experiment was repeated twice.
Salt Stress Tolerance—Solid medium that contained 2.5%
sucrose, 1% agar, 0.15% methyl paraben, 0.003% methylene
blue, and different concentrations of NaCl (0.4 or 0.8 M) was
prepared in vials. Fifty young adultmales of each genotypewere
introduced into these vials (25 flies per vial) and scored for
survival over the next 4 days. Each experiment was repeated
three times.
Heat Shock Induction—Wild type and diap2E151 mutant 3rd
instar larvae carrying an hs-diap1-dsRNA construct were
transferred to 1.5-ml microcentrifuge tubes and subjected to
10, 20, or 30 min of heat treatment in a 37 °C water bath. Each
experiment was repeated in triplicate. For the induction of Rel-
ishRHD, adult wild type or diap2mutant male flies carrying hs-
RelishRHD were subjected to a 30-min heat shock at 37 °C and
allowed to recover for 6 h at 25 °C before total RNAwas isolated
to quantify levels of antimicrobial peptide gene induction.
RNA Analysis—Total RNA was isolated from whole flies
using the TRIzol reagent (Invitrogen). For real time PCR anal-
ysis, cDNAs were synthesized with the Superscript III reverse
transcriptase system (Invitrogen). An amount of cDNA equiv-
alent to 0.3 g of total RNA was subjected to 40 cycles of PCR
amplification for 15 s at 95 °C and a 1-min incubation at 60 °C.
The output was monitored using SYBR Green core reagents
and the ABI Prism 7900 system (Applied Biosystems). All
results were normalized to the levels of rp49mRNA. Individual
primer sequences are available upon request.
Protein Analysis—For immunoblot analysis, 20 adult flies
were homogenized in lysis buffer (20 mM HEPES-KOH (pH
7.6), 150mMNaCl, 10% glycerol, 1%TritonX-100, 2mMEDTA,
and 1 protease inhibitor (Roche Applied Science)) and then
subjected to SDS-PAGE. After transfer to a nitrocellulose
membrane, proteins were probed withmouse antibodies raised
against DIAP2 (1:50), DIAP1 (25) (1:100), the C-terminal
domain of Relish (29) (1:5; a generous gift from Svenja Sto¨ven
and Dan Hultmark, Umeå University, Umeå, Sweden), and
tubulin (1:1,000; Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City). DIAP2 antibodies were gener-
ated in mouse using a GST-DIAP2 fusion protein as the
immunogen. Conditions for immunohistochemistry and con-
focal microscopy were described previously (25). Antibodies
were used at the following concentrations: mouse anti-P35 (25)
(1:100), mouse anti-DIAP2 (1:50), and rat anti-Relish (30)
(1:1000, a generous gift from Young-Joon Kim, Yonsei Univer-
sity, Seoul, Korea).
Caspase Activity Assay—Fifteen wild type and diap2E151
mutant adult flieswere homogenized in 100l of lysis buffer. 30
g of each extract was added into 100 l of caspase activity
buffer (70.4 mM HEPES (pH 7.5), 140.8 mM NaCl, 1.4 mM
EDTA, 0.14% CHAPS, 14.1% sucrose, 3.5 mM dithiothreitol,
5.6% glycerol, and 0.7%TritonX-100) in the presence of 100M
Ac-DEVD-AFC (EMD Biosciences). Caspase activity was
measured at 27 °C using a fluorometric plate reader (Fmax;
Molecular Devices) in the kinetic mode with excitation and
emission wavelengths of 405 and 510 nm, respectively. Assays
were performed in triplicate.
Gene Switch System—Flies carrying the adult fat body gene
switch driver S106 in different genetic backgrounds were placed
in empty vials with eight 3MM filter paper disks overnight (20
h) (31). To induce gene expression, disks were wetted with 800
l of 500 M RU486 (Sigma) in 2% sucrose solution. Following
immune challenge, flies were allowed to recover in normal fly
food vials for 4 h prior to RNA preparation.
RESULTS
Generation of diap2 Deletion mutants; diap2 Is Dispensable
for Development—To examine DIAP2 (CG8293) functions in
vivo, we generated two diap2 deletion mutants, diap2E151 and
diap2E119, via imprecise excision of the P element G2534,
which is located 100 bp upstream of the diap2 start codon (Fig.
1a). diap2E119 deletes840 bp and diap2E1511,460 bp down-
streamof the original P element insertion site, without affecting
neighboring genes (Fig. 1b). RT-PCR andWestern blot analysis
failed to detect full-length diap2 mRNA or protein in either
mutant (Fig. 1, c and d, and Fig. 5a). Truncated diap2 tran-3 C. Chen and B. Hay, manuscript in preparation.
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scripts are detectable in diap2E151
and diap2E119 animals. However,
these transcripts are unlikely to gen-
erate functional proteins because
multiple in-frame start and stop
codons precede the remaining
C-terminal diap2 coding sequences.
Together these results suggest that
diap2E151 and diap2E119 represent
null alleles. Introduction of a 7.4-kb
genomic fragment encoding wild
type diap2 (diap27.4Wt) or a point
mutant of diap2 with a mutation in
the RING domain (diap27.4C472Y)
into the diap2E151 mutant back-
ground resulted in expression of a
full-length diap2 transcript (Fig. 1, a
and c) and protein (Fig. 5a). In con-
trast to mutations in diap1 (alleles
of th), which are lethal early in
embryogenesis, animals homozy-
gous for diap2E151 and diap2E119
are viable, healthy, and fertile.
Therefore, diap2 is dispensable for
most, if not all, developmental cell
death.
DIAP2 Does Not Inhibit Multiple
Caspases, and Its Removal Does Not
Sensitize Flies to Multiple Apoptotic
Stimuli—In accordance with previ-
ous observations, overexpression of
DIAP2 in the developing eye sup-
pressed cell death induced by RHG
protein overexpression (supple-
mental Fig. 1a) (2). However,
removing diap2 had little if any
effect on RHG overexpression-in-
duced apoptosis in the eye (Fig. 2a).
Expression of diap2 also failed to
suppress death induced by expres-
sion ofDronc, Drice, Strica (Fig. 2b),
and Dcp-1 (data not shown), indi-
cating that DIAP2 does not inhibit
the activity of multiple caspases,
despite its structural and sequence
similarity to DIAP1. This failure is
particularly noteworthy in the case
of Dronc and Drice, which are the
central mediators of RHG-depend-
ent cell death in the fly eye (32–36).
These observations call into ques-
tion the idea that DIAP2 normally
functions as a cell death inhibitor.
To explore this issue further, we
exposed animals lacking DIAP2 to
several stresses that lead ultimately
to cell and organismal death as fol-
lows: X-irradiation, the free radical
FIGURE 2. DIAP2 fails to inhibit multiple caspases and does not act as a significant inhibitor of death
induced by expression of Rpr-, Hid-, X-irradiation, the free radical generator paraquot, or salt stress.
a, removal of diap2 fails to enhance cell death induced by Rpr or Hid overexpression.Wt, wild type. Adult eyes
of various genotypes are shown: GMR-lgRpr/, E151/E151; GMR-lgRpr/, GMR-Hid/, and E151/E151; GMR-
Hid/. b, DIAP2 overexpression in the fly eyes does not suppress cell death induced by expression of Strica,
Dronc, or Drice. Genotypes are as follows: GMR-Strica/; and GMR-Strica;GMR-DIAP2 (top row), GMR-Dronc/
and GMR-Dronc/GMR-DIAP2 (middle row), GMR-DriceP20, GMR-DriceP10/ and GMR-DriceP20, GMR-Dri-
ceP10/GMR-DIAP2 (bottom row). Loss of diap2 does not confer sensitivity to x-ray induced stress (c), the free
radical generator paraquot (d), or high salt (e).
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generator paraquat; andhigh salt, an activator of the p38MAPK
pathway (24, 37). If the physiological role of diap2 is to prevent
cell death, removal of diap2 should render animals more sensi-
tive to these stresses. However, compared with wild type or
diap2E151 flies carrying the diap27.4Wt rescue construct,
diap2E151 mutant flies did not exhibit increased sensitivity to
any of these stresses (Fig. 2, c–e). Finally, we tested the hypoth-
esis that diap2 functions as a minor apoptosis inhibitor whose
activity is only required in the absence of a major cell death
inhibitor such as diap1. We transiently knocked down diap1
levels in the third instar larvae using RNAi, in the presence or
absence of diap2, and scored for larval survival (see “Materials
and Methods”). Decreasing diap1 in the presence of diap2
resulted in almost complete lethality (10% survival), whereas
in the absence of diap2many more larvae survived (35% sur-
vival) (supplemental Fig. 2a). Therefore, although our results
do not exclude the possibility that diap2 plays an anti-apoptotic
role in some context, they strongly suggest that diap2 normally
plays little, if any role, in the regulationof the canonical caspase-
dependent apoptosis pathway.
DIAP2 Is Required to Defend against Gram-negative Bacte-
rial Infection—Bacterial infection, and the response to bacterial
infection, constitutes a formof organismal and tissue stress that
channels limited resources into a range of new tasks (19). Most
notably, infection results in the activation of a multipronged
immune response that involves phagocytosis, a melanin-pro-
ducing phenol oxidase reaction, and a humoral response that
leads to the expression of anti-microbial peptides and activa-
tion of the JNK signaling pathway (38–40). Two pathways, the
Toll and IMD, mediate induction of the humoral response.
In the Toll pathway, infection by Gram-positive bacteria or
fungi triggers activation of the Toll receptor, which leads ulti-
mately to the expression of AMPs such as drosomycin (38, 41,
42). The IMD pathway is activated in response to infection by
Gram-negative bacteria when receptors such as PGRP-LC/ird7
bind Gram-negative peptidoglycan (26, 39, 43). PGRP-LC
recruits IMD, which activates two downstream pathways. In
one branch, IMD binds to dFADD (44), which recruits the
caspase DREDD (45, 46). DREDD promotes (directly or indi-
rectly) the cleavage of the REL/NF-B family member Relish in
the cytoplasm (27, 47, 48). Once liberated from REL-49, the
C-terminal IB-like inhibitory domain, the N-terminal REL-68
fragment, which contains the DNA binding Rel homology
domain, translocates to the nucleus where it drives the expres-
sion of AMPs such as diptericin, attacin, cecropin, and defensin
(49). IMD also activates, through unknown mechanisms, the
MAPK kinase kinase dTAK1 (50–52). dTAK1 is required to
activate (perhaps through direct phosphorylation) the Dro-
sophila signalosome equivalent (50, 52), which consists of
homologs of the kinase IKK(ird5), and an accessory subunit
IKK(kenny) (53–55). The activated IKK complex phospho-
rylates Relish (48, 53), and this phosphorylation is required for
Dredd-dependent cleavage of Relish (48).
When exposed to the Gram-positive bacteria S. aureus, wild
type, diap2E151, and diap2E119 flies died at similar rates (Fig.
3a). This suggests that diap2 does not function as a general
inhibitor of organismal death in response to bacterial infection
or as an essential component of the Toll pathway. In contrast,
when exposed to theGram-negative bacteriaE. cloacae animals
lacking diap2were much more sensitive than wild type flies. In
fact, diap2E151 and diap2E119 adults died at a rate similar to that
ofanimals lackingIMD(Fig.3b),whichisessential for theRelish-
dependent production of Gram-negative-specific AMPs.
Importantly, these phenotypes were completely suppressed in
the presence of the wild type diap27.4Wt rescue transgene, dem-
onstrating that they are due to loss of diap2. diap2E151 and
diap27.4Wt flies actually showed greater resistance to infection
than wild type flies (Fig. 3b), although they had decreased lon-
gevity in the absence of immune stimulation.4 The basis for this
increased resistance is unknown, but it is interesting to specu-
late that it might reflect the fact that endogenous diap2 levels
are set so as to optimize an evolutionary compromise between
immune resistance and longevity, a feature not retained with
our transgene insertion. Finally, survival was not rescued in the
presence of the diap2 rescue transgene containing a point
mutation in the RING domain, diap27.4C472Y, even though
expression levels of wild type and mutant transgene mRNA
(Fig. 1c) and protein (Fig. 3c and Fig. 5a) were similar.
To determine whether diap2 regulates the production of
AMPs, we infectedwandering third instar larvae carrying a dip-
tericin-GFP reporter construct (27) with E. cloacae. Wild type
animals, as well as diap2E151 animals carrying a copy of the
diap27.4Wt rescue transgene, showed strong GFP expression in
response to infection (Fig. 3d). In contrast, GFP was undetect-
able in diap2E151 and diap2E119 animals, suggesting that diap2
mutants are unable to mount an effective immune response.
We also examined AMP expression using quantitative
RT-PCR.When challenged with E. cloacae,wild type adult flies
exhibited robust induction of attacin and diptericin. In con-
trast, the increases in attacin and diptericin were dramatically
suppressed in diap2E151 and diap2E119 flies, even after 12 h (Fig.
3e). Importantly, these phenotypes were significantly sup-
pressed in the presence of diap27.4Wt but not diap27.4C472Y (Fig.
4a). We note that the levels of the diap27.4Wt transgene were
lower than those of endogenous diap2 (Fig. 1c) and that dipteri-
cin expression levels were rescued to a somewhat lesser extent
than those of attacin (Fig. 4a). Thismay simply indicate that the
attacin promoter contains cis elements that buffer changes in
the concentration of processed Relish whereas the diptericin
promoter drives transcription in a manner directly propor-
tional to the level of Relish expression, a question that requires
further exploration. In any case, animals lacking diap2 also
failed to express two other Gram-negative-specific AMPs,
cecropin and defensin, in response to bacterial challenge, sug-
gesting a general failure to induce IMD-dependent antimicro-
bial peptide expression (Fig. 4b). In contrast to these observa-
tions with diap2 mutants, when the number of copies of wild
type diap2 was increased from two (the endogenous chromo-
somal copies) to six ( four copies of diap27.4Wt), the levels of
antimicrobial peptide expression in response to immune chal-
lenge underwent amodest increase (supplemental Fig. 2d). This
observation is potentially interesting because it suggests that
regulation of diap2 levelsmay serve to control the intensity and
4 J. R. Huh, unpublished observations.
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kinetics of the immune response. To localize the site of diap2
action, we used micro-RNA-based RNAi5 to reduce diap2 lev-
els specifically in the adult fat body, the insect analog of the
mammalian liver, and the major site of AMP synthesis. As
shown in Fig. 4c, this treatment phenocopied the immune
defects observed in diap2E151 and diap2E119 animals, thereby
identifying the fat body as a major site of the diap2 function.
The lack of AMP expression in diap2mutants could be due
to death, degeneration, or altered cell fate in the fat body. Sev-
eral observations suggest this is unlikely. First, apoptotic effec-
tor caspase activity (cleavage of the substrate DEVD) was not
increased in diap2 mutants before or after immune challenge
(supplemental Fig. 2b). Second, fat body morphology in
diap2E151 larvae (Fig. 5b) or adults (not shown) was indistin-
guishable from that of comparably staged wild type animals.
Third, the expression of drosomycin, which is induced in the fat
body in response to fungal or Gram-positive bacterial infec-
tions, was not significantly diminished in diap2 mutants (Fig.
4d, upper panel). Finally, Gram-negative bacterial infection
results in the TAK-dependent induction of the JNK pathway
immediate-early response genes puckered and CG13482 in the
fat body (28, 51). However, the levels of puckered (Fig. 4d, lower5 C. Chen and B. Hay, manuscript in preparation.
FIGURE 3. DIAP2 is required for survival and antimicrobial peptide induction following infection by Gram-negative bacteria. Fifty adult males of the
indicated genotypes were immune challenged with S. aureus (a) or E. cloacae (b), and survival wasmonitored on a daily basis. Surviving flies were counted up
to 9 or 15 days after infection, respectively. The results shown are representative of two (a) or three (b) independent experiments.Wt, wild type. c,Western blot
of adult flies probed with DIAP2 and Drice antibodies. Similar level of DIAP2 are expressed in wild type flies and diap2E151 flies carrying the diap27.4C472 rescue
construct.d,Gram-negativebacterial infection induces the expressionof adiptericin-GFP reporter gene in the fat bodyofwild type anddiap2E151;diap27.4Wt flies
but not in diap2E151 or diap2E119 mutants. e, real time PCR analysis of attacin and diptericin transcript levels at different time points in wild type (gray bars),
diap2E151 (white bars), ordiap2E119 (light gray bars) adult flies after immune challengeswith E. cloacae. Attacin anddiptericin expression are strongly suppressed
in flies lacking diap2. Error bars represent the standard deviation of three independent experiments.
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panel) andCG13482 (supplemental Fig. 2c) expression induced
by immune challenge were similar in wild type, diap2E151, and
diap2E119 flies. Altogether, these observations argue that the
immune defects in diap2 mutants are not due to nonspecific
effects on the fat body, such as increased cell death, and that
DIAP2 is not required for the Toll-dependent immune
response or Tak1-dependent JNK activation (28, 30, 51, 52, 56).
Instead they suggest that the primary function of diap2 is as an
essential component of the humoral response to Gram-nega-
tive bacterial infection.
DIAP2, Including Its RING Domain, Is Required for Relish
Function in the IMDPathway—Activation of the IMD-depend-
ent immune response ultimately leads to Dredd-dependent
cleavage of the NF-B-like transcription factor Relish (27, 47,
48). The resulting cleaved N-terminal product, RelishRHD (Rel
homology domain), translocates into the nucleus and functions
as a transcription activator for the induction of various AMP
genes (49). Since diap2E151 animals lack IMD-dependent
immune responses but have normal Toll-dependent signaling,
we examined the fate of Relish in response to immune activa-
tion using an antibody that recognizes the C-terminal half of
Relish (29). In unchallengedwild type animals, Relishwas found
mostly in the precursor form, although small amounts of pro-
cessed Relish could also be observed (Fig. 5a, left panel). Relish
processing was greatly increased post-challenge in wild type
flies but not in flies lacking Dredd or Imd, which are required
for challenge-dependent Relish cleavage. Flies lacking diap2
showed a low level of challenge-independent Relish processing,
FIGURE 4. Expression of IMD-dependent antimicrobial peptides but not drosomycin, Toll pathway-dependent antimicrobial peptide, or puckered, a
JNK target gene, are dramatically reduced in animals lacking diap2. a, attacin and diptericin expression in response to immune challenge are strongly
suppressed indiap2E151 flies, and these responses are restored in thepresenceofdiap27.4Wt,but notdiap27.4C472Y. Real timePCRanalysis of attacin anddiptericin
transcripts inwild type (gray bars),diap2E151 (white bars),diap2E151;diap27.4Wt (light gray bars), ordiap2E151;diap27.4C472Y (black bars) adult flies following immune
challenge. Error bars represent standard deviation of three independentmeasurements. b, real time PCR analysis of cecropin A1 and defensin transcript levels
inwild type (gray bars) or diap2E151 (white bars) adult flies after infectionswith E. cloacae. Data representmean S.D. of three experiments. c, down-regulation
of diap2 in the fat body using micro-RNA-dependent RNAi suppresses attacin and diptericin expression. The c564-Gal4 line expresses the transcriptional
activator Gal4 in the adult fat body. This was used in conjunction with UAS-diap2-miRNA to target the diap2mRNA for degradation. Real time PCR analysis of
attacin and diptericin transcript levels in adult flies carrying c564-Gal4/; dipt-GFP/ (gray bars) or c564-Gal4/uas-diap2-miRNA; dipt-GFP/ (white bars) after
immunechallengeswith E. cloacae. Data representmeanS.D. of three experiments.d, real timePCRofdrosomycin andPuckered transcript levels inwild type
(gray bars), diap2E151 (white bars), or diap2E119 (light gray bars) adult flies after immune challenge with E. cloacae. Data represent mean  S.D. of three
experiments.
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similar to that observed in unchallenged wild type flies. How-
ever, they showed only a modest increase in Relish cleavage in
response to immune challenge. Importantly, high levels of
challenge-dependent Relish cleavage were restored in the pres-
ence of the diap2 wild type rescue transgene (diap27.4Wt) but
not in the presence of the Ring mutant form (diap27.4C472Y).
Together, these observations indicate that diap2 is required to
bring about normal levels of Relish cleavage and that this
requires DIAP2 RING function. However, they also indicate
that some challenge-independent, as well as challenge-depend-
ent Relish cleavage (or stabilization of the C-terminal Relish
cleavage product), occurs in the absence of diap2. Nuclear
translocation of RelishRHD, which occurs rapidly following
immune stimulation in wild type animals, was undetectable in
diap2E151 animals (Fig. 5b). As with Relish cleavage, the defect
in Relish nuclear translocation was eliminated in the presence
of the diap2 genomic rescue transgene (Fig. 5, a and b).
The diap27.4C472Y rescue trans-
gene contains a point mutation in
the RING domain. Mutation of the
corresponding residue in DIAP1
results in a loss of DIAP1 E3 ligase
activity (25). As noted above,
diap2E151 and diap27.4C472Y flies
were as sensitive to E. cloacae infec-
tion as diap2E151 flies and failed to
induce attacin and diptericin
expression in response to infection
(Figs. 3b and 4a). As shown in Fig.
5a, Relish processing was largely
blocked in these animals. These
results suggest the DIAP2 RING,
perhaps functioning as an E3 ligase,
is required for Relish processing or
other aspects of Relish function. As
a further test of this hypothesis,
we introduced the diap27.4C472Y
genomic rescue fragment, which
expresses wild type levels of
diap2C472Y (Fig. 3C), into awild type
background. If the RING domain
normally functions to promote
ubiquitination of a substrate protein
that is tethered to DIAP2 through
interactions involving other se-
quences such as the BIRs, then
RING mutated versions of DIAP2
might be expected to function
as dominant negatives. Consistent
with this hypothesis, the presence of
diap27.4C472Y in a wild type back-
ground resulted in a 50% suppres-
sion of diptericin expression in
response to Gram-negative bacte-
rial infection (supplemental Fig. 2d).
To determine whether diap2 is
required downstream of Relish
cleavage, we asked if ectopic expres-
sion of cleavedRelish (RelishRHD), in thediap2E151background,
was sufficient to activate AMP expression. Indeed, heat shock-
driven expression of RelishRHD resulted in levels of diptericin
and attacin expression in diap2E151 homozygous animals simi-
lar to those observed in diap2E151 heterozygotes (Fig. 5c and
data not shown). This result indicates that DIAP2 is not abso-
lutely required for Relish function post-cleavage. However, we
note that the levels of cleaved Relish induced in the fat body in
these experiments may be higher than in wild type and that
cleaved Relish may normally be modified and/or function as a
part of a complex, nuclear translocation, and/or function of
which may require interaction with DIAP2. Given these uncer-
tainties, and the observation that while loss of diap2 reduces
Relish cleavage it causes a more profound defect in AMP pro-
duction, it remains possible that DIAP2 also has important
roles downstream of Relish cleavage, as recently suggested by
others (16). In either case, our observations demonstrate that
FIGURE5.DIAP2promotes cleavageandnuclear translocationof theNF-B transcription factorRelish in
response to immune challenge. a, immunoblots of protein extracts (protein amount equivalent to three
adult male flies) from untreated () and immune-challenged (heat-killed Escherichia coli) () flies of various
genotypes, probed sequentially with anti-Relish C-terminal, anti-DIAP2, and anti-tubulin antibodies. The left
and right panels are fromdifferent gels but are from the same experiment. Inwild type and diap2E151;diap27.4Wt
flies, a 49-kDa Relish C-terminal fragment is present 1 h after immune challenge as a result of endoproteolytic
processing. Cleavage of Relish is not observed in dredd, imd, and diap2E151 flies carrying diap27.4C472Y. As with
wild type flies, diap2E151 flies show low levels of the C-terminal Relish cleavage product prior to immune
challenge. However, in contrast to wild type flies, these levels increase modestly 1 h post-challenge. b, immu-
nostaining of endogenous Relish in the 3rd instar larval fat bodies of various genotypes. Wild type fat body
before (upper left) and1hafter (upper right) immunechallengewith E. cloacae. Relish is not localized to fat body
nuclei in immune-challenged diap2E151 flies (lower left), but nuclear localization is restored in diap2E151 flies
carrying diap27.4Wt. Lower right, c, heat shock-induced expression of RelishRHD results in immune challenge-
independent expression of diptericin in diap2E151 heterozygotes and homozygotes.
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DIAP2 has an important role in promoting normal levels of
Relish cleavage in response to immune challenge.
The DIAP2 BIR Serves as a Potential Point of Cross-talk
between Apoptotic and Immune Signaling—IAP BIR domains
contain a surface groove that is bound by proteins containing a
short peptide motif, the IBM (supplemental Fig. 4) (6). RHG
proteins bind DIAP1 BIRs via such IBMs and in doing so com-
pete off bound proteins and promote DIAP1 degradation. The
BIR domains of DIAP2 are very similar to those of DIAP1 (2),
and RHG proteins can bind DAP2 BIR domains through inter-
actions that require their IBMs (4, 11, 12, 57). To explore the
possibility that IBM-containing proteins can also regulate
DIAP2 function, we expressed Rpr or Hid in the posterior com-
partment of a simple easy to visualize tissue, the wing imaginal
disc, using the UAS-GAL4 system (see “Materials and Meth-
ods”) and examined DIAP2 levels. The baculovirus caspase
inhibitor p35 was coexpressed along with these molecules to
block cell death. Expression of p35 alone had no effect on
DIAP2 expression, which was uniform throughout the wing
disc (Fig. 6, a and b). In contrast, coexpression of Rpr or Hid
with P35 resulted in a dramatic reduction of DIAP2 in the pos-
terior wing compartments (Fig. 6, c–f), similar to that seen for
DIAP1 (25, 58). These results suggest thatDIAP2, likeDIAP1, is
down-regulated in cells undergoing apoptosis.
Why might apoptosing cells choose to down-regulate
DIAP2?One possibility is that this helps to prevent inappropri-
ate immune activation in response to the presence of proin-
flammatory molecules released by dying cells. To explore this
possibility, we created cells in which apoptosis effectors were
activated at modest levels in the fat body (thereby inducing low
levels of death) but in which this activation occurred independ-
ent of expression of RHG proteins (thus preventing down-reg-
ulation of diap2 that would occur in response to their expres-
sion). We did this by targeting diap1 mRNA for degradation
specifically in the adult fat body, using a drug-inducible, fat
body Gal4 driver (31), and a UAS-diap1-targeted micro-RNA
(UAS-diap1-miRNA) that is known to promote the loss of
diap1 when expressed in other tissues (supplemental Fig. 1, d
and e). As illustrated in supplemental Fig. 2e, a 20-h induction
of UAS-diap1-miRNA had no negative effect on expression of
theGram-positive immune response gene drosomycin, indicat-
ing that the fat body was still largely intact. In contrast, with
diptericin, a Gram-negative response gene, a modest 20%
increase in expression was seen. Most importantly, however,
this increase in diptericin was suppressed by coexpression of a
micro-RNA targeting diap2 (UAS-diap2-miRNA) that is
known to promote the loss of diap2 when expressed in other
tissues (supplemental Fig. 1, b and c). No significant change in
drosomycin expression was observed. Together, these observa-
tions suggest amodel in which activation of apoptosis signaling
pathways (which often involves decreasing diap1 levels) can
lead (through unknown mechanisms) to hyperactivation of
immune responses unless diap2 is also removed.
DISCUSSION
DIAP1 and DIAP2 both inhibit apoptosis when overex-
pressed, and DIAP1 is essential for the survival of many cells.
Here we show that endogenous diap2 does not function as a
major regulator of apoptosis. DIAP2 expression does not
inhibit the activity of multiple caspases, including the key apo-
ptosis activatorsDrice andDronc. In addition, animals inwhich
diap2 is deleted are viable, healthy, fertile, and as resistant as
wild type animals to a number of stresses. The fact that DIAP2
can inhibit apoptosis when overexpressed probably reflects, at
least in part, its ability to sequester and/or degrade apoptosis
inducers that also target DIAP1, such as the RHG proteins. In
this study, we show that DIAP2, perhaps functioning as a E3
ubiquitin ligase, is required for the IMD-mediated humoral
response to Gram-negative bacterial infection, with DIAP2
being required for normal levels of Relish cleavage and nuclear
translocation. DIAP2 may also function at other steps in the
IMDpathway, although it is not absolutely required onceRelish
has undergone cleavage, at least when the cleaved version of
Relish is expressed directly (see below). Finally, we observed
modest but significant increases in the immune response when
the endogenous DIAP2 genetic dosage was increased and a
strong down-regulation of DIAP2 levels in the presence of the
apoptosis inducers Rpr and Hid. As discussed further below,
these observations suggest models in which IMD signaling is
FIGURE 6. Expression of Hid or Rpr leads to loss of DIAP2 in Drosophila
wing discs. Confocal images of wing discs from third instar larvae of various
genotypes. Posterior is to the right. a, wing disc from third instar larvae of
genotype UAS::p35; engrailed Gal4 (en::Gal4), stained with anti-P35, in red.
b, wing disc in a stained with anti-DIAP2 in green. c, UAS::Rpr, UAS:p35;
en:Gal4 wing disc stained with anti-P35, in red. d, wing disc in c stained with
anti-DIAP2, in green. e, wing disc of genotype UAS:Hid, UAS:p35; en:Gal4
stainedwith anti-P35, in red. f,wingdisc in e stainedwith anti-DIAP2, in green.
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sensitive to the levels of DIAP2, and IBM-containing proteins
regulate DIAP2 function during apoptosis and perhaps other
contexts, through interactions with its BIR domains.
Our observations, derived from in vivo studies of deletion
mutants, stand in contrast to several recent reports, in which
down-regulation of diap2 was brought about by using long
dsRNA to induce RNAi-dependent degradation of diap2
mRNA. RNAi of diap2 was reported to sensitize S2 cells to
several cell death activators (14) and to result in pupal lethality
when expressed ubiquitously (16). Differences between these
results and our own are most simply explained as a result of
RNAi off-targeting of unknown transcripts required for cell
health and organismal viability in the earlier works. The
500-bp dsRNAs used in the above-mentioned studies have
the potential to be diced into many different 21-bp fragments
for loading into the RISC complex and subsequent use as guide
sequences. A number of recent reports have shown that off-
targeting is a frequent occurrence (59–61) and can result in the
production of toxic phenotypes (62). The basis for this has been
made clear through experiments demonstrating that a single
RISC-bound guide sequence can target many mRNA
sequences, which need be only partially complementary to the
guide strand (59, 63, 64).
Two groups, again using long dsRNA to target diap2 in S2
cells, have also recently reported that diap2 is required for the
IMD response. One group concluded that diap2 acted
upstream of or at the level of TAK1 (17). This conclusion was
based, in part, on the observation that reduction of diap2
resulted in decreased expression of the dTAK1- and JNK-de-
pendent early response gene puckered following immune chal-
lenge. In contrast, we found that expression of puckered, and a
second early response gene, CG13482, were induced normally
in animal mutants for diap2 (Fig. 4d, lower panel, and supple-
mental Fig. 2c), making this site of action unlikely (see also
below). How can these different observations be reconciled?
One possibility is that differences in the systems are important.
We measured immune responses in the context of the entire
organism. In doing this our observations reflect the summed
action of (and potentially cross-talk between) multiple cell
types and signaling pathways. In contrast, cell line-based stud-
ies are, by their nature, much more focused. Thus, it seems not
unreasonable to postulate that while Tak-dependent activation
of JNK and/or JNK target genes may be sensitive to levels of
diap2 in one cell type, a different pathway may dominate in the
intact organism. Alternatively, the effects of RNAi-mediated
knockdown of diap2 on puckered expression in S2 cells may
again reflect off-targeting of unknown transcripts by long
dsRNA.
In contrast to Gesellchen et al. (17), Kleino et al. (16) pro-
posed DIAP2 functions in the IMD pathway downstream of
Relish cleavage because they saw no effect of diap2 RNAi on
Relish cleavage in S2 cells. This difference from our observa-
tions, in which loss of diap2 resulted in a significant decrease in
Relish cleavage, may indicate differences in systems. However,
we think it more likely to reflect the difficulty in generating null
mutant phenotypes for diap2 using RNAi. These authors did
find that expression of pre-cleaved Relish was able to activate
the immune response (and thus presumably able to translocate
into the nucleus) in cells treated with diap2 dsRNA. Impor-
tantly, we observed a similar ability of precleaved Relish to acti-
vate transcription of AMP in the complete absence of diap2 in
flies.
What do these observations tell us about the site(s) of DIAP2
action? Our observations demonstrate that DIAP2 plays a role
in bringing about Relish cleavage, which is required for Relish
nuclear translocation and function (29). Does DIAP2 function
at other steps as well? The fact that loss of DIAP2 had a greater
effect on nuclear translocation of endogenous Relish (Fig. 5b)
and AMP production (Figs. 3 and 4) than it did on Relish cleav-
age (Fig. 5) is consistentwith the hypothesis that itmay. Expres-
sion of pre-cleaved Relish bypassed the requirement for DIAP2
in AMP production (Fig. 5c) (16), suggesting that DIAP2 is not
absolutely required for Relish nuclear translocation or func-
tion. In addition, we have not observed nuclear translocation of
DIAP2 in response to immune challenge.6 However, these
observations do not exclude the possibility that the levels of
pre-cleaved Relish generated in the fat body by heat shock are
so high that Relish enters the nucleus through unphysiological
pathways. For example, perhaps overexpression of pre-cleaved
Relish titrates out an inhibitor of Relish nuclear translocation/
function that is normally removed by DIAP2. It is also worth
considering that pre-cleaved Relish expressed from a transgene
may not be the same as processed Relish generated in response
to IMD signaling. For example, endogenous Relish is phospho-
rylated by the IKK complex in response to IMD signaling (48,
52) and cleaved by Dredd. Processed endogenous Relish (but
perhaps not transgene-expressed pre-cleaved Relish) may exist
as a part of a complex and/or interact with factors that inhibit
nuclear import unless DIAP2 promotes their removal. These
hypotheses can best be explored through the identification of
proteins that bind endogenous cleaved Relish and DIAP2.
Finally, what is the significance ofDIAP2-independent cleavage
of Relish? Perhaps DIAP2 is not absolutely essential, mechanis-
tically, for Relish cleavage (for example, if it acts as an inhibitor
of an inhibitor of cleavage, someRelishmay escape the inhibitor
and thus be cleaved). Alternatively, other related E3s such as
DIAP1 may be able to partially substitute for DIAP2 function
(at least when DIAP2 is completely missing), an issue that
requires further exploration. Regardless, our observation that
loss of DIAP2 prevents a significant fraction of Relish cleavage
and that DIAP2 is required for Relish-dependent AMP expres-
sion demonstrates that DIAP2 is a critical regulator of Relish
function.
How does DIAP2 regulate Relish cleavage? It is unlikely that
DIAP2 functions as an inhibitor of the caspase Dredd since
DIAP2 does not inhibit other tested caspases, and Dredd,
like DIAP2, is required for activation of the IMD pathway.
However, it is worth noting that several mammalian IAPs that
inhibit apoptosis when overexpressed, cIAP1 and cIAP2, bind
active caspases even though they do not function as caspase
inhibitors (65). Binding of DIAP2 to Drice and Strica has been
reported (4). Binding between DIAP2 and Dredd has not been
reported (it is not clear it has been searched for). Thus, it
6 J. R. Huh and B. A. Hay, unpublished data.
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remains possible that interactions between Dredd and DIAP2,
perhaps involving ubiquitination by DIAP2, positively regulate
Dredd activation, activity, or substrate targeting. Roles for E3
ligase activity of DIAP2 in the IMD pathway activation
(upstream and/or downstream of Relish cleavage) are sug-
gested by several observations. Expression of a RING domain
point mutant version of diap2, diap27.4C472Y, in the diap2E151
mutant background failed to rescue Relish cleavage and IMD
signaling (Figs. 3–5). In contrast, expression of this same
mutant protein in a wild type background suppressed the IMD
response, suggesting dominant negative activity (supplemental
Fig. 2d). In mammals, ubiquitination exerts degradation-de-
pendent effects on immunity through removal of IB and proc-
essing of NF-B. In contrast, activation of Tak1 and the IKK
complex require ubiquitination in degradation-independent
roles (66, 67). As discussed in the Introduction, Drosophila
counterparts of Tak1 and the IKK complex are also essential for
Relish processing. However, several observations suggest that
diap2 does not act at the level of dTAK1. First, as noted above,
expression of puckered and CG13482, immediate transcrip-
tional targets of the Tak1-JNK signaling module (30), are not
affected indiap2mutant flies (Fig. 4d and supplemental Fig. 2c).
Second, ectopic expression or down-regulation of diap2 in the
fly eye fails to influence Tak1-dependent cell killing, which is
JNK-dependent (20) (supplemental Fig. 3). Recent observations
suggest that activation of the IKK complex requires the Dro-
sophila ubiquitin-carrier proteins Bendless (Ubc13) and
dUEV1a, along with a yet to be identified E3 ubiquitin ligase
(68). Both Ubc13 (MAALTP) and dUEV1a (MANTSS) contain
potential IBMmotifs at their N termini. It will be interesting to
determinewhetherDIAP2 binds one or both these proteins and
participates in this process.
Careful control over the intensity and timing of an immune
response is important, because hyperactivation of the immune
system induces fitness costs with respect to other aspects of the
organism life cycle such as fertility and longevity. Hyperactiva-
tion can also lead to the induction of tissue inflammation and
cell death (18, 19). In the context of these considerations, it is
interesting that modest increases in the genetic dose of diap2
resulted in an enhanced immune response, whereas expression
of cell death activators such as Rpr orHid brought aboutDIAP2
removal. Rpr and Hid, as well as other members of the RHG
family, are induced or released from a sequestering environ-
ment in response to stresses that can lead to cell death and/or
tissue damage. We speculate that in binding DIAP2 as well as
DIAP1, these proteins accomplish two goals at once. They
induce cell death through inhibition ofDIAP1 and prevent acti-
vation of an immune response, which requires cleavage of Rel-
ish by the caspase Dredd, a process likely to be stimulated by
loss of DIAP1 (a caspase inhibitor) and/or the activation of
other caspases downstream of this loss. In other words, RHG
protein binding to DIAP2 BIR domains may function in some
contexts as a safety lock, down-regulating DIAP2 function,
thereby preventing an inappropriate immune response in con-
texts in which there are high levels of cell death (perhaps during
metamorphosis or larval fat body histolysis) or cell-damaging
stress (Fig. 7a).This model is speculative, but it is testable and
provides an explanation (perhaps partial) for the observation
that unlike necrotic cell death, which often leads to inflamma-
tion, apoptotic cell death is characterized by a lack of inflam-
mation, and sometimes even immunosuppression (69, 70).
Evidence consistent with such a model comes from our obser-
vation that activation of apoptosis effectors directly (by
decreasing DIAP1), rather than through expression of RHG
proteins (which would also down-regulate DIAP2), resulted in
an increased immune response (supplemental Fig. 2e).
Related, alternative models can also be considered. For
example, caspase cleavage exposes IBM-like motifs in many
proteins (71). If this occurs in response to Dredd activation in
the insect fat body, it could serve as a form of negative feedback,
creating proteins that bind DIAP2 BIRs, displacing bound pro-
teins required (we speculate) for the immune response, and/or
promoting changes in DIAP2 localization or stability. Target
genes activated by the immune response might play a similar
role (Fig. 7b). RNAi in S2 cells of several transcripts encoding
proteins with N-terminal sequences similar to those of known
IAP-binding proteins or peptides (supplemental Fig. 4) results
in increased immune activation (72), suggesting these as candi-
date negative regulators of DIAP2. IBM domain proteins might
also play positive roles in immune regulation. In the context of
this possibility, it is interesting to note that binding of themam-
malian IBM protein Smac/Diablo promotes XIAP stabilization
rather than degradation (73, 74). The hypothesis that IBM
proteins regulate DIAP2 activity, in its capacity as an essential
component of the innate immune system, is speculative but is
testable. Given that IBM domain proteins function as evolu-
tionarily conserved regulators of cell death by displacing IAP-
bound proteins and promoting IAP degradation and that
DIAP2 is able to bind proteins with these samemotifs, it would
be surprising if similar regulatorymechanismswere not utilized
in the immune system.
FIGURE 7. Speculative models for DIAP2 regulation by IBM proteins.
a, cells undergoing apoptosis often express combinations of RHG proteins
such as Rpr, Hid, andGrim, thereby promoting removal of DIAP1 and caspase
activation. DIAP1 inhibits (by one of several different mechanisms) all tested
Drosophila caspases. Therefore, if DIAP1 is normally required to limit Dredd
activity (directly or indirectly), decreasing DIAP1 levels should lead (all other
things being equal) to hyperactivation of an immune response. The fact that
DIAP2 is also targeted by RHG proteins and is required for the IMD response
may serve to limit this possibility. b, in an alternative scenario, activation of
the IMD pathway may lead to the creation (through caspase cleavage) or
expression of novel IBM proteins that regulate the stability of DIAP2 or its
ability to interact with immune effectors. Such proteins could include a neg-
ative feedback loop. Indeed, several geneswith potential IBMmotifs (CG9646
and CG12113) were previously identified as suppressors of the IMD pathway
in S2 cells (72).
Drosophila IAP2Mutant Analysis
2066 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282•NUMBER 3•JANUARY 19, 2007
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on January 28, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
Acknowledgments—We thank Drs. Loren Miller and Todd Ciche for
providing us with S. aureus and E. cloacae bacterial strains; Jules
Hoffmann, Bruno Lemaitre, Makoto Nakamura, Kathryn Anderson,
Ronald Davis, and Carl Thummel for fly stocks; Lark Kyun Kim,
Young Joon Kim, Svenja Sto¨ven, and Dan Hultmark for antibodies;
Nieng Yan, Yigong Shi, and Carl Thummel for plasmids; Rainbow
Transgenic Flies for generating fly transformants; Kelvin Nguyen for
help during the early stages of this work; and Eric Davidson for use of
the real time PCR machine.
Addendum—A recent report also described the characterization of
Drosophila IAP2 mutant flies (75). These authors placed DIAP2
function downstream or in parallel to Relish because diap2 mutant
phenotypes were not rescued by ectopic expression of full-length
Relish. However, since DIAP2 plays a significant role in promoting
Relish cleavage (our study), a failure of full-length Relish (which
requires cleavage) to rescue immune responsiveness in diap2
mutants is not surprising.
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